Cargando…
Developing Therapies to Improve Antiviral Immunity in Older Adults
Autor principal: | Mannick, Joan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7743685/ http://dx.doi.org/10.1093/geroni/igaa057.1717 |
Ejemplares similares
-
LB2. TORC1 Inhibition with RTB101 as a Potential Pan-Antiviral Immunotherapy to Decrease the Incidence of Respiratory Tract Infections Due to Multiple Respiratory Viruses in Older Adults
por: Mannick, Joan, et al.
Publicado: (2019) -
Challenges with Conducting an Investigational Drug Study in Older Adults in Nursing Homes During a Pandemic
por: Davidson, H Edward, et al.
Publicado: (2021) -
Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials
por: Mannick, Joan B, et al.
Publicado: (2021) -
Tackling immunosenescence to improve COVID-19 outcomes and vaccine response in older adults
por: Cox, Lynne S, et al.
Publicado: (2020) -
TORC1 INHIBITION AS AN IMMUNOTHERAPY TO DECREASE INFECTIONS IN THE ELDERLY
por: Mannick, Joan
Publicado: (2019)